Patent ID: 8026377

Claim:
A process of making 3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt of Formula I, the method comprising: (a) reacting a compound of Formula II with a compound of Formula III, to form a compound of Formula of IV (wherein R is alkyl, aryl or arylalkyl); (b) reacting the compound of Formula IV with benzaldehyde to form a compound of Formula V; (c) reacting the compound of Formula V with 4-fluorobenzaldehyde to form a compound of Formula VI; (d) reacting the compound of Formula VI with a compound of Formula VII, to form the compound of Formula VIII; (e) deprotecting the compound of Formula VIII to form a compound of Formula IX; (f) reducing the compound of Formula IX in the presence of a reducing agent and a hydrocarbon solvent to form a compound of Formula X; (g) deprotecting the compound of Formula X to form a compound of Formula XI; and (h) converting the compound of Formula XI to compound of Formula I in ethanol:water (4:1) in presence of calcium hydroxide and a phase transfer catalyst selected from the group consisting of tetraalkylammonium halide, tetrabutylammonium hydrogen sulfate, tetrabutylammonium thiocyanate, tetrabutylammonium tetrafluoroborate, benzyltributylammonium chloride and tetraalkylphosphonium halide, wherein purification of products of the steps (a) to (h) is carried out without using column chromatography, and the reaction in step (h) involves a one-pot conversion of compound of Formula XI to the calcium salt of Formula I.